The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
Top Cited Papers
Open Access
- 21 January 2015
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 36 (4), 395-402
- https://doi.org/10.1002/humu.22758
Abstract
Analyzing the type and frequency of patient‐specific mutations that give rise to Duchenne muscular dystrophy (DMD) is an invaluable tool for diagnostics, basic scientific research, trial planning, and improved clinical care. Locus‐specific databases allow for the collection, organization, storage, and analysis of genetic variants of disease. Here, we describe the development and analysis of the TREAT‐NMD DMD Global database (http://umd.be/TREAT_DMD/). We analyzed genetic data for 7,149 DMD mutations held within the database. A total of 5,682 large mutations were observed (80% of total mutations), of which 4,894 (86%) were deletions (1 exon or larger) and 784 (14%) were duplications (1 exon or larger). There were 1,445 small mutations (smaller than 1 exon, 20% of all mutations), of which 358 (25%) were small deletions and 132 (9%) small insertions and 199 (14%) affected the splice sites. Point mutations totalled 756 (52% of small mutations) with 726 (50%) nonsense mutations and 30 (2%) missense mutations. Finally, 22 (0.3%) mid‐intronic mutations were observed. In addition, mutations were identified within the database that would potentially benefit from novel genetic therapies for DMD including stop codon read‐through therapies (10% of total mutations) and exon skipping therapy (80% of deletions and 55% of total mutations).Keywords
Funding Information
- TREAT-NM (FP6LSHM-CT-2006-036825, 20123307 UNEW_FY2013, AFM 16104)
- European Union Seventh Framework Programme (FP7/2007-2013)
This publication has 34 references indexed in Scilit:
- Novel Approaches to Corticosteroid Treatment in Duchenne Muscular DystrophyPhysical Medicine and Rehabilitation Clinics of North America, 2012
- Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohortHuman Mutation, 2009
- Standards of Care for Duchenne Muscular Dystrophy: Brief Treat-NMD RecommendationsAdvances in Experimental Medicine and Biology, 2009
- Recommendations for locus-specific databases and their curationHuman Mutation, 2007
- Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMDGene Therapy, 2006
- Experience and Strategy for the Molecular Testing of Duchenne Muscular DystrophyThe Journal of Molecular Diagnostics, 2005
- UMD (Universal Mutation Database): 2005 updateHuman Mutation, 2005
- Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patientBrain & Development, 2001
- Are CpG sites mutation hot spots in the dystrophin gene?Human Molecular Genetics, 1994
- Characterization of Dystrophin in Muscle-Biopsy Specimens from Patients with Duchenne's or Becker's Muscular DystrophyThe New England Journal of Medicine, 1988